Financial Ratios

SYNCOM HEALTHCARE LTD.

NSE : SYNCOMBSE : 533157ISIN CODE : INE602K01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE4.120 (0 %)
PREV CLOSE ( ) 4.12
OPEN PRICE ( ) 3.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 163615
TODAY'S LOW / HIGH ( )3.95 4.33
52 WK LOW / HIGH ( )3.95 4.33
NSE4.200 (0 %)
PREV CLOSE( ) 4.20
OPEN PRICE ( ) 4.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 4.20 (50)
VOLUME 332739
TODAY'S LOW / HIGH( ) 3.95 4.30
52 WK LOW / HIGH ( )3.95 4.3
Select year
ParticularsMar2020Mar2019Mar2018Mar2017Mar2016
Operational & Financial Ratios
   Earnings Per Share (Rs)-2.93-2.85-16.38-19.45-0.88
   CEPS(Rs)-2.36-2.12-15.45-18.300.28
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-3.10-0.232.6219.0239.79
   Tax Rate(%)0.000.000.00-11.3118.46
Margin Ratios
   Core EBITDA Margin(%)-9.15-2.91-12.46-4.291.01
   EBIT Margin(%)-57.24-17.16-155.91-125.23-1.62
   Pre Tax Margin(%)-58.69-17.81-156.58-131.03-6.88
   PAT Margin (%)-58.69-17.81-156.58-145.86-5.61
   Cash Profit Margin (%)-47.22-13.23-147.65-137.221.75
Performance Ratios
   ROA(%)-34.83-20.70-73.53-50.03-1.82
   ROE(%)0.00-238.67-151.43-66.16-2.20
   ROCE(%)-66.73-37.68-94.84-45.67-0.54
   Asset Turnover(x)0.591.160.470.340.32
   Sales/Fixed Asset(x)0.832.651.741.511.36
   Working Capital/Sales(x)-1.48-17.05-14.632.951.65
Efficiency Ratios
   Fixed Capital/Sales(x)1.210.380.570.660.73
   Receivable days165.3198.67160.09172.52165.72
   Inventory Days83.2447.3188.6882.6377.34
   Payable days407.16200.73259.53105.6081.13
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-0.31-0.96-0.30-0.3122.57
   Price/Book(x)-0.24-9.041.750.300.16
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.270.481.030.920.87
   EV/Core EBITDA(x)-16.23-19.69-8.93-4765.6115.12
   EV/EBIT(x)-2.23-2.79-0.65-0.73-53.61
   EV/CE(x)1.430.620.700.410.28
   M Cap / Sales0.150.130.440.430.40
Growth Ratio
   Net Sales Growth(%)-68.8654.40-21.40-16.021.71
   Core EBITDA Growth(%)-0.6467.350.00-100.28-20.59
   EBIT Growth(%)-3.8883.142.34-6450.96-29.76
   PAT Growth(%)-2.6482.5715.79-2102.827.61
   EPS Growth(%)-2.6482.5715.79-2102.797.61
Financial Stability Ratios
   Total Debt/Equity(x)-1.91-26.492.380.340.20
   Current Ratio(x)0.260.900.941.552.30
   Quick Ratio(x)0.150.720.731.221.84
   Interest Cover(x)-39.54-26.54-232.51-21.57-0.31
   Total Debt/Mcap(x)8.102.931.361.141.25

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.